Total

n = 344

TTR ≤ 70%

n = 283

TTR > 70%

n = 61

OR

95%CI

p

Age < 60 years

183 (53.2)

140 (49.5)

43 (70.5)

2.44

1.34 - 4.43

0.003

Male

151 (43.9)

117 (41.34)

34 (55.74)

1.78

1.02 - 3.12

0.04

Urban residence

326 (94.8)

268 (94.7)

58 (95.1)

1.08

0.30 - 3.84

0.90

University level

84 (24.4)

68 (24.3)

16 (26.2)

1.12

0.59 - 2.11

0.71

Total autonomy

309 (89.8)

251 (88.7)

58 (95.1)

2.46

0.72 - 8.32

0.14

INR monitoring by the patient himself

240 (69.8)

188 (66.4)

52 (85.3)

2.91

1.37 - 6.17

0.005

High blood pressure

92 (26.7)

80 (28.3)

12 (19.7)

0.62

0.31 - 1.23

0.17

Diabetes

18 (5.2)

15 (5.3)

3 (4.9)

0.92

0.25 - 3.29

0.90

Obesity

9 (2.6)

6 (2.1)

3 (4.2)

2.38

0.58 - 9.82

0.22

Heart failure

115 (33.4)

97 (34.3)

18 (29.5)

0.80

0.43 - 1.46

0.47

Fluindione

246 (71.5)

189 (66.8)

57 (93.4)

7.08

2.49 - 20.1

0.0002

≥3 medications

202 (58.7)

175 (61.8)

27 (4.3)

175

0.28 - 0.85

0.01

Loop diuretics

173 (50.3)

146 (51.6)

27 (44.3)

0.74

0.42 - 1.29

0.30

Spironolactone

151 (43.9)

130 (45.9)

21 (34.4)

0.61

0.34 - 10

0.10

Beta blockers

159 (46.2)

138 (48.8)

21 (34.4)

0.55

0.30 - 0.98

0.04

ACE inhibitors

158 (45.9)

137 (48.4)

21 (34.4)

0.55

0.31 - 0.99

0.04

Digoxin

18 (5.2)

12 (4.2)

6 (9.8)

2.46

0.88 - 6.84

0.08

Proton pump inhibitors

68 (19.8)

50 (17.7)

18 (29.5)

1.95

1.03 - 3.66

0.03

Low-dose aspirin

30 (8.7)

18 (6.4)

12 (19.7)

3.60

1.63 - 7.95

0.001

≥365 days of anticoagulation

271 (78.8)

223 (78.8)

48 (78.7)

1.00

0.51 - 1.97

0.98